Can a vaccine prevent genital warts from returning after surgery?

NCT ID NCT02750202

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving the HPV vaccine (Gardasil) to women with large or extensive genital warts before surgery could prevent the warts from coming back. The trial included 52 women, some with HIV and some without. Researchers measured changes in wart size and antibody levels over 60 weeks to see if the vaccine boosted the immune response and improved outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Quadrivalent HPV vaccine (Gardasil)

What this could lead to

If it works, this could offer a way to reduce the high recurrence rate of genital warts after surgery, especially in women with HIV.

What could go wrong

This is a small, completed Phase 3 trial with only 52 participants, so results may not apply to everyone. The vaccine may not prevent recurrence in all cases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENITAL WARTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anogenital human papillomavirus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Steve Biko Academic Hospital

    Pretoria, Gauteng, South Africa

  • Tygerberg Hospital

    Cape Town, Western Cape, South Africa